Lifevantage Corp financial data

Symbol
LFVN on Nasdaq
Industry
Pharmaceutical Preparations
Location
3300 Triumph Blvd, Suite 700, Lehi, UT
Fiscal year end
June 30
Former names
LIFELINE THERAPEUTICS, INC. (to 12/6/2006), YAAK RIVER RESOURCES INC (to 9/28/2004)
Latest financial report
10-Q - Q4 2024 - Feb 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 170 % -11.1%
Quick Ratio 68.4 % -6.89%
Debt-to-equity 128 % +15.8%
Return On Equity 26.6 % +180%
Return On Assets 11.7 % +159%
Operating Margin 5.11 % +192%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.6M shares -2.47%
Common Stock, Shares, Outstanding 12.6M shares -2.56%
Entity Public Float 68.1M USD +54.1%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 12.2M shares -3.18%
Weighted Average Number of Shares Outstanding, Diluted 13.2M shares +4.48%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 212M USD +0.57%
Research and Development Expense 900K USD +50%
Operating Income (Loss) 10.8M USD +194%
Nonoperating Income (Expense) -542K USD -317%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 10.3M USD +161%
Income Tax Expense (Benefit) 2.96M USD +203%
Net Income (Loss) Attributable to Parent 7.34M USD +148%
Earnings Per Share, Basic 0.6 USD/shares +161%
Earnings Per Share, Diluted 0.56 USD/shares +143%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 16.9M USD -21.8%
Accounts Receivable, after Allowance for Credit Loss, Current 2.09M USD -10.6%
Inventory, Net 17.5M USD +16.7%
Assets, Current 45.8M USD +18.4%
Deferred Income Tax Assets, Net 5.78M USD +25.2%
Property, Plant and Equipment, Net 7.14M USD -20.4%
Operating Lease, Right-of-Use Asset 8.92M USD -6.41%
Intangible Assets, Net (Excluding Goodwill) 257K USD -33.9%
Other Assets, Noncurrent 645K USD +24.5%
Assets 68.5M USD +9.33%
Accounts Payable, Current 5.76M USD -7.7%
Accrued Liabilities, Current 7.87M USD -0.73%
Contract with Customer, Liability, Current 1.4M USD +55.6%
Liabilities, Current 27.5M USD +19.7%
Operating Lease, Liability, Noncurrent 10.9M USD -10.3%
Other Liabilities, Noncurrent 206K USD -8.44%
Liabilities 38.6M USD +9.22%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.81M USD -51.4%
Retained Earnings (Accumulated Deficit) -106M USD +0.48%
Stockholders' Equity Attributable to Parent 29.9M USD +9.46%
Liabilities and Equity 68.5M USD +9.33%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -583K USD -112%
Net Cash Provided by (Used in) Financing Activities -1.83M USD +72.6%
Net Cash Provided by (Used in) Investing Activities -345K USD +69.6%
Common Stock, Shares Authorized 40M shares 0%
Common Stock, Shares, Issued 12.6M shares -2.56%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.29M USD +28.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 21.6M USD +24.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8K USD
Deferred Tax Assets, Valuation Allowance 720K USD +2.27%
Deferred Tax Assets, Gross 8.55M USD +8.81%
Operating Lease, Liability 12.8M USD -7.33%
Payments to Acquire Property, Plant, and Equipment 349K USD -69.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.87M USD
Lessee, Operating Lease, Liability, to be Paid 14.2M USD -8.08%
Operating Lease, Liability, Current 1.89M USD +14.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.32M USD +17.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.31M USD +19.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Deferred Income Tax Expense (Benefit) -515K USD +69.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.44M USD -14.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.05M USD +1.29%
Deferred Tax Assets, Operating Loss Carryforwards 271K USD +8.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.77M USD -14%
Operating Lease, Payments 1.97M USD -29%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 797K USD -13.2%
Share-based Payment Arrangement, Expense 1.7M USD +113%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%